25 XP   0   0   10

Australian Clinical Labs Ltd
Buy, Hold or Sell?

Let's analyse Australian Clinical Labs Ltd together

PenkeI guess you are interested in Australian Clinical Labs Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Australian Clinical Labs Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Australian Clinical Labs Ltd

I send you an email if I find something interesting about Australian Clinical Labs Ltd.

Quick analysis of Australian Clinical Labs Ltd (30 sec.)










What can you expect buying and holding a share of Australian Clinical Labs Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.12
When do you have the money?
1 year
How often do you get paid?
76.9%

What is your share worth?

Current worth
A$0.82
Expected worth in 1 year
A$0.75
How sure are you?
69.2%

+ What do you gain per year?

Total Gains per Share
A$0.12
Return On Investment
4.9%

For what price can you sell your share?

Current Price per Share
A$2.44
Expected price per share
A$2.2350748971193 - A$2.7790102836879
How sure are you?
50%

1. Valuation of Australian Clinical Labs Ltd (5 min.)




Live pricePrice per Share (EOD)

A$2.44

2. Growth of Australian Clinical Labs Ltd (5 min.)




Is Australian Clinical Labs Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$108.4m$139.2m-$26.9m-24.0%

How much money is Australian Clinical Labs Ltd making?

Current yearPrevious yearGrowGrow %
Making money$3.3m$18m-$14.7m-435.5%
Net Profit Margin1.5%4.4%--

How much money comes from the company's main activities?

3. Financial Health of Australian Clinical Labs Ltd (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#68 / 144

Most Revenue
#35 / 144

Most Profit
#35 / 144

What can you expect buying and holding a share of Australian Clinical Labs Ltd? (5 min.)

Welcome investor! Australian Clinical Labs Ltd's management wants to use your money to grow the business. In return you get a share of Australian Clinical Labs Ltd.

What can you expect buying and holding a share of Australian Clinical Labs Ltd?

First you should know what it really means to hold a share of Australian Clinical Labs Ltd. And how you can make/lose money.

Speculation

The Price per Share of Australian Clinical Labs Ltd is A$2.44. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Australian Clinical Labs Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Australian Clinical Labs Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.82. Based on the TTM, the Book Value Change Per Share is A$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Australian Clinical Labs Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.020.7%0.020.7%0.062.4%0.072.9%0.072.9%
Usd Book Value Change Per Share-0.02-1.0%-0.01-0.4%-0.03-1.1%0.041.7%0.041.7%
Usd Dividend Per Share0.051.9%0.031.3%0.135.4%0.072.8%0.072.8%
Usd Total Gains Per Share0.020.9%0.020.8%0.104.3%0.114.5%0.114.5%
Usd Price Per Share1.90-2.16-2.67-2.03-2.03-
Price to Earnings Ratio29.45-15.34-11.57-9.28-9.28-
Price-to-Total Gains Ratio89.92-74.66-36.34-42.43-42.43-
Price to Book Ratio3.53-3.87-3.87-4.05-4.05-
Price-to-Total Gains Ratio89.92-74.66-36.34-42.43-42.43-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.60308
Number of shares623
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.07
Usd Book Value Change Per Share-0.010.04
Usd Total Gains Per Share0.020.11
Gains per Quarter (623 shares)12.2968.78
Gains per Year (623 shares)49.15275.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
176-2739172103265
2153-5588344206540
3229-82137516309815
4306-1091866894121090
5382-1372358615151365
6459-16428410336181640
7535-19133312057211915
8612-21938213778242190
9688-24643115499272465
10765-273480172110302740

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.00.01.066.7%10.00.01.090.9%12.00.01.092.3%12.00.01.092.3%12.00.01.092.3%
Book Value Change Per Share0.02.01.00.0%3.03.05.027.3%3.04.06.023.1%3.04.06.023.1%3.04.06.023.1%
Dividend per Share2.00.01.066.7%9.00.02.081.8%10.00.03.076.9%10.00.03.076.9%10.00.03.076.9%
Total Gains per Share2.00.01.066.7%9.00.02.081.8%9.01.03.069.2%9.01.03.069.2%9.01.03.069.2%

Fundamentals of Australian Clinical Labs Ltd

About Australian Clinical Labs Ltd

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.

Fundamental data was last updated by Penke on 2024-04-20 18:44:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Australian Clinical Labs Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Australian Clinical Labs Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 1.5% means that $0.01 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Australian Clinical Labs Ltd:

  • The MRQ is 1.5%. The company is making a profit. +1
  • The TTM is 1.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.5%0.0%
TTM1.5%YOY4.4%-2.9%
TTM1.5%5Y6.4%-4.9%
5Y6.4%10Y6.4%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%-7.3%+8.8%
TTM1.5%-6.7%+8.2%
YOY4.4%-1.9%+6.3%
5Y6.4%-1.5%+7.9%
10Y6.4%-3.4%+9.8%
1.1.2. Return on Assets

Shows how efficient Australian Clinical Labs Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • 0.8% Return on Assets means that Australian Clinical Labs Ltd generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Australian Clinical Labs Ltd:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.9%0.0%
TTM0.9%YOY4.4%-3.5%
TTM0.9%5Y5.6%-4.7%
5Y5.6%10Y5.6%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%-1.3%+2.1%
TTM0.9%-1.3%+2.2%
YOY4.4%-0.9%+5.3%
5Y5.6%-0.5%+6.1%
10Y5.6%-0.9%+6.5%
1.1.3. Return on Equity

Shows how efficient Australian Clinical Labs Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • 3.0% Return on Equity means Australian Clinical Labs Ltd generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Australian Clinical Labs Ltd:

  • The MRQ is 3.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.0%TTM3.0%0.0%
TTM3.0%YOY13.1%-10.0%
TTM3.0%5Y16.0%-12.9%
5Y16.0%10Y16.0%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0%-0.5%+3.5%
TTM3.0%0.2%+2.8%
YOY13.1%-0.3%+13.4%
5Y16.0%-1.4%+17.4%
10Y16.0%-2.3%+18.3%

1.2. Operating Efficiency of Australian Clinical Labs Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Australian Clinical Labs Ltd is operating .

  • Measures how much profit Australian Clinical Labs Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • An Operating Margin of 5.6% means the company generated $0.06  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Australian Clinical Labs Ltd:

  • The MRQ is 5.6%. The company is operating less efficient.
  • The TTM is 4.1%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ5.6%TTM4.1%+1.6%
TTM4.1%YOY6.9%-2.9%
TTM4.1%5Y6.6%-2.5%
5Y6.6%10Y6.6%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6%-7.4%+13.0%
TTM4.1%0.5%+3.6%
YOY6.9%4.0%+2.9%
5Y6.6%3.7%+2.9%
10Y6.6%-1.3%+7.9%
1.2.2. Operating Ratio

Measures how efficient Australian Clinical Labs Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.94 means that the operating costs are $0.94 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Australian Clinical Labs Ltd:

  • The MRQ is 0.944. The company is less efficient in keeping operating costs low.
  • The TTM is 0.626. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.944TTM0.626+0.318
TTM0.626YOY0.431+0.195
TTM0.6265Y0.333+0.293
5Y0.33310Y0.3330.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9441.280-0.336
TTM0.6261.304-0.678
YOY0.4311.236-0.805
5Y0.3331.242-0.909
10Y0.3331.205-0.872

1.3. Liquidity of Australian Clinical Labs Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Australian Clinical Labs Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 0.66 means the company has $0.66 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Australian Clinical Labs Ltd:

  • The MRQ is 0.662. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.426. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.662TTM0.426+0.236
TTM0.426YOY0.634-0.208
TTM0.4265Y0.634-0.208
5Y0.63410Y0.6340.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6622.122-1.460
TTM0.4262.298-1.872
YOY0.6342.599-1.965
5Y0.6343.012-2.378
10Y0.6343.081-2.447
1.3.2. Quick Ratio

Measures if Australian Clinical Labs Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.53 means the company can pay off $0.53 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Australian Clinical Labs Ltd:

  • The MRQ is 0.528. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.343. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.528TTM0.343+0.185
TTM0.343YOY0.473-0.129
TTM0.3435Y0.489-0.145
5Y0.48910Y0.4890.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5281.230-0.702
TTM0.3431.345-1.002
YOY0.4731.661-1.188
5Y0.4891.957-1.468
10Y0.4892.295-1.806

1.4. Solvency of Australian Clinical Labs Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Australian Clinical Labs Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Australian Clinical Labs Ltd to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.72 means that Australian Clinical Labs Ltd assets are financed with 71.7% credit (debt) and the remaining percentage (100% - 71.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Australian Clinical Labs Ltd:

  • The MRQ is 0.717. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.708. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.717TTM0.708+0.009
TTM0.708YOY0.664+0.044
TTM0.7085Y0.757-0.048
5Y0.75710Y0.7570.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7170.429+0.288
TTM0.7080.407+0.301
YOY0.6640.394+0.270
5Y0.7570.448+0.309
10Y0.7570.446+0.311
1.4.2. Debt to Equity Ratio

Measures if Australian Clinical Labs Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 254.0% means that company has $2.54 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Australian Clinical Labs Ltd:

  • The MRQ is 2.540. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.433. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.540TTM2.433+0.107
TTM2.433YOY2.009+0.424
TTM2.4335Y2.089+0.344
5Y2.08910Y2.0890.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5400.606+1.934
TTM2.4330.571+1.862
YOY2.0090.603+1.406
5Y2.0890.651+1.438
10Y2.0890.734+1.355

2. Market Valuation of Australian Clinical Labs Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Australian Clinical Labs Ltd generates.

  • Above 15 is considered overpriced but always compare Australian Clinical Labs Ltd to the Diagnostics & Research industry mean.
  • A PE ratio of 29.45 means the investor is paying $29.45 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Australian Clinical Labs Ltd:

  • The EOD is 24.862. Based on the earnings, the company is fair priced.
  • The MRQ is 29.448. Based on the earnings, the company is overpriced. -1
  • The TTM is 15.337. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD24.862MRQ29.448-4.585
MRQ29.448TTM15.337+14.111
TTM15.337YOY11.567+3.770
TTM15.3375Y9.283+6.054
5Y9.28310Y9.2830.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD24.862-0.254+25.116
MRQ29.448-0.395+29.843
TTM15.337-0.199+15.536
YOY11.567-0.008+11.575
5Y9.2833.483+5.800
10Y9.2834.432+4.851
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Australian Clinical Labs Ltd:

  • The EOD is 1.766. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 2.092. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1.448. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.766MRQ2.092-0.326
MRQ2.092TTM1.448+0.644
TTM1.448YOY4.238-2.790
TTM1.4485Y2.267-0.819
5Y2.26710Y2.2670.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.766-0.315+2.081
MRQ2.092-0.441+2.533
TTM1.448-1.388+2.836
YOY4.238-2.175+6.413
5Y2.267-1.665+3.932
10Y2.267-1.971+4.238
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Australian Clinical Labs Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 3.53 means the investor is paying $3.53 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Australian Clinical Labs Ltd:

  • The EOD is 2.984. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.535. Based on the equity, the company is fair priced.
  • The TTM is 3.875. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.984MRQ3.535-0.550
MRQ3.535TTM3.875-0.340
TTM3.875YOY3.867+0.007
TTM3.8755Y4.049-0.175
5Y4.04910Y4.0490.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.9841.946+1.038
MRQ3.5352.228+1.307
TTM3.8752.168+1.707
YOY3.8673.002+0.865
5Y4.0493.517+0.532
10Y4.0494.125-0.076
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Australian Clinical Labs Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.038-0.017-56%-0.040+6%0.063-160%0.063-160%
Book Value Per Share--0.8180.847-3%1.050-22%0.566+44%0.566+44%
Current Ratio--0.6620.426+55%0.634+4%0.634+4%0.634+4%
Debt To Asset Ratio--0.7170.708+1%0.664+8%0.757-5%0.757-5%
Debt To Equity Ratio--2.5402.433+4%2.009+26%2.089+22%2.089+22%
Dividend Per Share--0.0700.047+50%0.199-65%0.105-33%0.105-33%
Eps--0.0250.025-4%0.091-73%0.106-77%0.106-77%
Free Cash Flow Per Share--0.3450.364-5%0.275+25%0.377-8%0.377-8%
Free Cash Flow To Equity Per Share--0.0610.053+15%-0.076+225%0.056+8%0.056+8%
Gross Profit Margin--1.0000.667+50%1.0000%0.923+8%0.923+8%
Market Cap492474960.000-18%583300260.000663361080.000-12%818941455.000-29%624288087.692-7%624288087.692-7%
Net Profit Margin--0.0150.015-3%0.044-66%0.064-77%0.064-77%
Operating Margin--0.0560.041+38%0.069-19%0.066-15%0.066-15%
Operating Ratio--0.9440.626+51%0.431+119%0.333+183%0.333+183%
Pb Ratio2.984-18%3.5353.875-9%3.867-9%4.049-13%4.049-13%
Pe Ratio24.862-18%29.44815.337+92%11.567+155%9.283+217%9.283+217%
Price Per Share2.440-18%2.8903.287-12%4.058-29%3.093-7%3.093-7%
Price To Free Cash Flow Ratio1.766-18%2.0921.448+45%4.238-51%2.267-8%2.267-8%
Price To Total Gains Ratio75.917-18%89.91874.656+20%36.338+147%42.429+112%42.429+112%
Quick Ratio--0.5280.343+54%0.473+12%0.489+8%0.489+8%
Return On Assets--0.0080.009-4%0.044-81%0.056-85%0.056-85%
Return On Equity--0.0300.030-1%0.131-77%0.160-81%0.160-81%
Total Gains Per Share--0.0320.030+7%0.158-80%0.168-81%0.168-81%
Usd Book Value--108424710.000112310865.000-3%139262976.000-22%75076249.154+44%75076249.154+44%
Usd Book Value Change Per Share---0.025-0.011-56%-0.026+6%0.041-160%0.041-160%
Usd Book Value Per Share--0.5370.556-3%0.690-22%0.372+44%0.372+44%
Usd Dividend Per Share--0.0460.031+50%0.131-65%0.069-33%0.069-33%
Usd Eps--0.0160.017-4%0.060-73%0.070-77%0.070-77%
Usd Free Cash Flow--45798813.00032153580.000+42%36526572.000+25%46214491.846-1%46214491.846-1%
Usd Free Cash Flow Per Share--0.2270.239-5%0.181+25%0.248-8%0.248-8%
Usd Free Cash Flow To Equity Per Share--0.0400.035+15%-0.050+225%0.037+8%0.037+8%
Usd Market Cap323556048.720-18%383228270.820435828229.560-12%538044535.935-29%410157273.614-7%410157273.614-7%
Usd Price Per Share1.603-18%1.8992.159-12%2.666-29%2.032-7%2.032-7%
Usd Profit--3253464.0003379608.000-4%18096490.125-82%21948550.615-85%21948550.615-85%
Usd Revenue--219253383.000146834901.000+49%134342538.750+63%147480125.538+49%147480125.538+49%
Usd Total Gains Per Share--0.0210.020+7%0.104-80%0.110-81%0.110-81%
 EOD+4 -4MRQTTM+15 -21YOY+14 -215Y+14 -2210Y+14 -22

3.2. Fundamental Score

Let's check the fundamental score of Australian Clinical Labs Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1524.862
Price to Book Ratio (EOD)Between0-12.984
Net Profit Margin (MRQ)Greater than00.015
Operating Margin (MRQ)Greater than00.056
Quick Ratio (MRQ)Greater than10.528
Current Ratio (MRQ)Greater than10.662
Debt to Asset Ratio (MRQ)Less than10.717
Debt to Equity Ratio (MRQ)Less than12.540
Return on Equity (MRQ)Greater than0.150.030
Return on Assets (MRQ)Greater than0.050.008
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Australian Clinical Labs Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.189
Ma 20Greater thanMa 502.469
Ma 50Greater thanMa 1002.541
Ma 100Greater thanMa 2002.724
OpenGreater thanClose2.400
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets583,723
Total Liabilities418,693
Total Stockholder Equity164,828
 As reported
Total Liabilities 418,693
Total Stockholder Equity+ 164,828
Total Assets = 583,723

Assets

Total Assets583,723
Total Current Assets125,761
Long-term Assets457,962
Total Current Assets
Cash And Cash Equivalents 24,938
Short-term Investments 657
Net Receivables 74,148
Inventory 16,805
Other Current Assets 9,213
Total Current Assets  (as reported)125,761
Total Current Assets  (calculated)125,761
+/-0
Long-term Assets
Property Plant Equipment 281,158
Long-term Assets Other 166,929
Long-term Assets  (as reported)457,962
Long-term Assets  (calculated)448,087
+/- 9,875

Liabilities & Shareholders' Equity

Total Current Liabilities189,992
Long-term Liabilities228,701
Total Stockholder Equity164,828
Total Current Liabilities
Short-term Debt 101,774
Accounts payable 41,243
Other Current Liabilities 45,815
Total Current Liabilities  (as reported)189,992
Total Current Liabilities  (calculated)188,832
+/- 1,160
Long-term Liabilities
Long-term Liabilities  (as reported)228,701
Long-term Liabilities  (calculated)0
+/- 228,701
Total Stockholder Equity
Common Stock792,140
Retained Earnings 146,249
Accumulated Other Comprehensive Income -773,561
Total Stockholder Equity (as reported)164,828
Total Stockholder Equity (calculated)164,828
+/-0
Other
Cash and Short Term Investments 25,595
Common Stock Shares Outstanding 201,331
Current Deferred Revenue1,160
Liabilities and Stockholders Equity 583,723
Net Debt 302,096
Net Working Capital -64,231
Short Long Term Debt Total 327,034



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
346,769
0
474,701
0
670,866
0
628,042
0
595,554
0
578,913
583,723
583,723578,9130595,5540628,0420670,8660474,7010346,769000
   > Total Current Assets 
112,100
112,100
84,300
84,300
117,226
117,226
208,106
208,106
142,871
142,871
121,552
121,552
0
115,959
125,761
125,761115,9590121,552121,552142,871142,871208,106208,106117,226117,22684,30084,300112,100112,100
       Cash And Cash Equivalents 
0
0
0
34,986
0
35,233
0
47,326
0
26,372
0
16,132
0
19,955
24,938
24,93819,955016,132026,372047,326035,233034,986000
       Short-term Investments 
0
0
0
5,246
0
5,661
0
8,369
0
1,134
0
7,586
0
632
657
65763207,58601,13408,36905,66105,246000
       Net Receivables 
63,310
63,310
53,700
53,700
62,976
62,976
130,734
130,734
91,140
91,114
80,281
80,281
0
73,710
74,148
74,14873,710080,28180,28191,11491,140130,734130,73462,97662,97653,70053,70063,31063,310
       Inventory 
10,498
10,498
14,200
14,200
13,356
13,356
21,677
21,677
20,088
20,088
17,553
17,553
0
15,092
16,805
16,80515,092017,55317,55320,08820,08821,67721,67713,35613,35614,20014,20010,49810,498
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
485,171
0
474,002
0
462,954
457,962
457,962462,9540474,0020485,171000000000
       Property Plant Equipment 
194,053
194,053
194,600
194,600
228,944
228,944
284,235
284,235
310,200
310,200
299,568
299,568
0
288,438
281,158
281,158288,4380299,568299,568310,200310,200284,235284,235228,944228,944194,600194,600194,053194,053
       Goodwill 
0
0
0
35,748
0
0
0
158,119
0
158,684
0
0
0
158,684
0
0158,684000158,6840158,11900035,748000
       Intangible Assets 
0
0
0
0
0
112,906
0
6,831
0
6,716
0
165,286
0
6,488
0
06,4880165,28606,71606,8310112,90600000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
150
0
210
0
1,111
166,929
166,9291,11102100150000000000
> Total Liabilities 
0
0
0
470,069
0
392,803
0
463,242
0
395,485
0
420,420
0
406,242
418,693
418,693406,2420420,4200395,4850463,2420392,8030470,069000
   > Total Current Liabilities 
135,466
135,466
155,900
155,900
166,176
166,176
252,050
252,050
225,163
225,163
191,978
191,978
0
187,925
189,992
189,992187,9250191,978191,978225,163225,163252,050252,050166,176166,176155,900155,900135,466135,466
       Short-term Debt 
0
0
0
0
0
-190
0
0
0
94,767
0
97,296
0
101,085
101,774
101,774101,085097,296094,767000-19000000
       Accounts payable 
12,890
12,890
40,000
40,000
17,025
17,025
68,528
68,528
26,468
26,468
40,101
40,101
17,966
17,966
41,243
41,24317,96617,96640,10140,10126,46826,46868,52868,52817,02517,02540,00040,00012,89012,890
       Other Current Liabilities 
22,579
22,579
51,700
51,700
36,175
36,175
95,966
95,966
57,597
11,822
54,581
54,523
25,086
145
45,815
45,81514525,08654,52354,58111,82257,59795,96695,96636,17536,17551,70051,70022,57922,579
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
170,322
0
228,442
0
218,317
228,701
228,701218,3170228,4420170,322000000000
       Long term Debt Total 
0
0
0
283,931
0
224,055
0
198,284
0
167,610
0
225,781
0
0
0
000225,7810167,6100198,2840224,0550283,931000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
190
0
0
0
167,610
0
-97,296
0
149,538
-101,774
-101,774149,5380-97,2960167,61000019000000
> Total Stockholder Equity
0
0
0
-123,300
0
81,898
0
207,624
0
232,444
0
174,960
0
172,417
164,828
164,828172,4170174,9600232,4440207,624081,8980-123,300000
   Common Stock
146,505
146,505
47,100
47,100
797,975
797,975
797,975
797,975
793,031
793,031
797,975
792,140
0
792,140
792,140
792,140792,1400792,140797,975793,031793,031797,975797,975797,975797,97547,10047,100146,505146,505
   Retained Earnings 
-79,033
-79,033
0
-694,801
-70,594
-70,594
192,409
192,409
83,432
216,220
158,914
158,914
22,453
155,241
146,249
146,249155,24122,453158,914158,914216,22083,432192,409192,409-70,594-70,594-694,8010-79,033-79,033
   Accumulated Other Comprehensive Income -773,561-774,9640-776,0940-776,807000000000
   Capital Surplus 000000000000000
   Treasury Stock0000000-4,9440000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue692,103
Cost of Revenue-126,083
Gross Profit566,020566,020
 
Operating Income (+$)
Gross Profit566,020
Operating Expense-514,053
Operating Income51,85051,967
 
Operating Expense (+$)
Research Development0
Selling General Administrative297,394
Selling And Marketing Expenses0
Operating Expense514,053297,394
 
Net Interest Income (+$)
Interest Income182
Interest Expense-3,540
Other Finance Cost-10,325
Net Interest Income-13,683
 
Pretax Income (+$)
Operating Income51,850
Net Interest Income-13,683
Other Non-Operating Income Expenses0
Income Before Tax (EBT)48,31041,824
EBIT - interestExpense = 48,310
48,169
39,441
Interest Expense3,540
Earnings Before Interest and Taxes (EBIT)51,85051,850
Earnings Before Interest and Taxes (EBITDA)174,605
 
After tax Income (+$)
Income Before Tax48,310
Tax Provision-12,268
Net Income From Continuing Ops36,04236,042
Net Income35,901
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses640,136
Total Other Income/Expenses Net10,02613,683
 

Technical Analysis of Australian Clinical Labs Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Australian Clinical Labs Ltd. The general trend of Australian Clinical Labs Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Australian Clinical Labs Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Australian Clinical Labs Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.72 < 2.7443962765957 < 2.7790102836879.

The bearish price targets are: 2.36 > 2.36 > 2.2350748971193.

Tweet this
Australian Clinical Labs Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Australian Clinical Labs Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Australian Clinical Labs Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Australian Clinical Labs Ltd. The current macd is -0.04558289.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Australian Clinical Labs Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Australian Clinical Labs Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Australian Clinical Labs Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Australian Clinical Labs Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAustralian Clinical Labs Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Australian Clinical Labs Ltd. The current adx is 31.28.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Australian Clinical Labs Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Australian Clinical Labs Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Australian Clinical Labs Ltd. The current sar is 2.37475005.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Australian Clinical Labs Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Australian Clinical Labs Ltd. The current rsi is 42.19. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Australian Clinical Labs Ltd Daily Relative Strength Index (RSI) ChartAustralian Clinical Labs Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Australian Clinical Labs Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Australian Clinical Labs Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Australian Clinical Labs Ltd Daily Stochastic Oscillator ChartAustralian Clinical Labs Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Australian Clinical Labs Ltd. The current cci is -52.35903337.

Australian Clinical Labs Ltd Daily Commodity Channel Index (CCI) ChartAustralian Clinical Labs Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Australian Clinical Labs Ltd. The current cmo is -11.38080277.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Australian Clinical Labs Ltd Daily Chande Momentum Oscillator (CMO) ChartAustralian Clinical Labs Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Australian Clinical Labs Ltd. The current willr is -57.89473684.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Australian Clinical Labs Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Australian Clinical Labs Ltd Daily Williams %R ChartAustralian Clinical Labs Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Australian Clinical Labs Ltd. The current atr is 0.06452908.

Australian Clinical Labs Ltd Daily Average True Range (ATR) ChartAustralian Clinical Labs Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Australian Clinical Labs Ltd. The current obv is -58,750,020.

Australian Clinical Labs Ltd Daily On-Balance Volume (OBV) ChartAustralian Clinical Labs Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Australian Clinical Labs Ltd. The current mfi is 31.12.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Australian Clinical Labs Ltd Daily Money Flow Index (MFI) ChartAustralian Clinical Labs Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Australian Clinical Labs Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-03STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Australian Clinical Labs Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Australian Clinical Labs Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.189
Ma 20Greater thanMa 502.469
Ma 50Greater thanMa 1002.541
Ma 100Greater thanMa 2002.724
OpenGreater thanClose2.400
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Australian Clinical Labs Ltd with someone you think should read this too:
  • Are you bullish or bearish on Australian Clinical Labs Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Australian Clinical Labs Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Australian Clinical Labs Ltd

I send you an email if I find something interesting about Australian Clinical Labs Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Australian Clinical Labs Ltd.

Receive notifications about Australian Clinical Labs Ltd in your mailbox!